Fisher Asset Management LLC Cuts Stock Holdings in Haleon plc (NYSE:HLN)

Fisher Asset Management LLC decreased its position in Haleon plc (NYSE:HLN - Free Report) by 2.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 14,770,278 shares of the company's stock after selling 394,113 shares during the quarter. Fisher Asset Management LLC owned about 0.32% of Haleon worth $121,559,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HLN. FinTrust Capital Advisors LLC raised its position in shares of Haleon by 93.7% in the 3rd quarter. FinTrust Capital Advisors LLC now owns 5,557 shares of the company's stock valued at $46,000 after purchasing an additional 2,688 shares in the last quarter. Bank of New York Mellon Corp grew its stake in shares of Haleon by 71.3% in the third quarter. Bank of New York Mellon Corp now owns 1,495,001 shares of the company's stock worth $12,453,000 after purchasing an additional 622,041 shares in the last quarter. Brown Advisory Inc. boosted its stake in Haleon by 9.8% during the third quarter. Brown Advisory Inc. now owns 36,323 shares of the company's stock valued at $303,000 after buying an additional 3,233 shares in the last quarter. Sage Mountain Advisors LLC bought a new position in Haleon during the third quarter valued at about $113,000. Finally, Park Avenue Securities LLC lifted its holdings in shares of Haleon by 12.8% during the third quarter. Park Avenue Securities LLC now owns 91,880 shares of the company's stock valued at $765,000 after purchasing an additional 10,431 shares during the last quarter. Hedge funds and other institutional investors own 6.67% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on HLN. Argus reissued a "buy" rating on shares of Haleon in a research note on Tuesday, March 26th. HSBC began coverage on Haleon in a report on Wednesday, April 17th. They issued a "buy" rating on the stock. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, Haleon currently has an average rating of "Moderate Buy".

Haleon Trading Down 0.2 %

Shares of Haleon stock traded down $0.02 during trading on Friday, reaching $8.30. 11,740,715 shares of the company were exchanged, compared to its average volume of 4,833,312. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. Haleon plc has a twelve month low of $7.70 and a twelve month high of $8.98. The business has a 50-day moving average price of $8.33 and a 200-day moving average price of $8.29. The firm has a market capitalization of $37.90 billion, a price-to-earnings ratio of 27.67, a P/E/G ratio of 2.18 and a beta of 0.28.

Haleon Dividend Announcement

The business also recently announced a semi-annual dividend, which will be paid on Thursday, May 16th. Investors of record on Friday, March 15th will be issued a dividend of $0.1064 per share. The ex-dividend date is Thursday, March 14th. This represents a yield of 1.8%. Haleon's payout ratio is presently 70.00%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.